Monitoring of QT-prolonging drugs: How big is the risk and how can pharmacists reduce it;Bewaking van QT-tijd-verlenging

Pharmaceutisch Weekblad

Volumn 142, Issue 17, 2007, Pages 30-33

  Langendijk, Pirn ^a   De Bruin, Marieke ^b   Tan, Hanno ^a   Wilde, Arthur ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DRUG MONITORING; HUMAN; PHARMACIST; QT PROLONGATION; RISK ASSESSMENT; RISK MANAGEMENT; RISK REDUCTION;

EID: 34347359588     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)